Kirenol inhibits RANKL-induced osteoclastogenesis and prevents ovariectomized-induced osteoporosis via suppressing the Ca2+-NFATc1 and Cav-1 signaling pathways
Binhua Zou(Southern Medical University), Xiaojuan Li(Second People Hospital of Hunan), Ligang Jie(Zhujiang Hospital), Minhong Ke(Southern Medical University), Wende Deng(Southern Medical University), Zongbao Ding(Southern Medical University), Yan Chen(Sun Yat-sen University), Qinghong Yu(Zhujiang Hospital), Yuan Qu(Zhujiang Hospital), Yanhui Tan(Guangxi Normal University), Jiehuang Zheng(Guangdong Pharmaceutical University), Qin Yang(University of Electronic Science and Technology of China)
Cited by 46
Related Papers
Oral Hydrogel Microbeads-Mediated In Situ Synthesis of Selenoproteins for Regulating Intestinal Immunity and Microbiota
|Journal of the American Chemical Society|2023|177
Synergetic delivery of triptolide and Ce6 with light-activatable liposomes for efficient hepatocellular carcinoma therapy
|Acta Pharmaceutica Sinica B|2021|158
Self-targeting visualizable hyaluronate nanogel for synchronized intracellular release of doxorubicin and cisplatin in combating multidrug-resistant breast cancer
|Nano Research|2020|145
Artesunate attenuates LPS-induced osteoclastogenesis by suppressing TLR4/TRAF6 and PLCγ1-Ca2+-NFATc1 signaling pathway
|Acta Pharmacologica Sinica|2019|120
Delivery of triptolide with reduction-sensitive polymer nanoparticles for liver cancer therapy on patient-derived xenografts models
|Chinese Chemical Letters|2020|97